Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05534932 · ClinicalTrials.gov registry record · NA
Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women
A NA study of Preeclampsia Postpartum, sponsored by University of Chicago.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05534932: Active NA study of Preeclampsia Postpartum, sponsored by University of Chicago.
NCT05534932 is a NA study of Preeclampsia Postpartum that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 20 participants, below the 72-participant average among 8 other Preeclampsia Postpartum trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05534932, a NA study of Preeclampsia Postpartum, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, open-label pilot study looking at how Guideline-directed management and therapy (GDMP) in post-partum women with preeclampsia can improve Global Longitudinal Strain (GLS).
Primary Outcome
Compare GLS levels as a percentage (%) at 3 months between patients who received RPM program those in the observational group.
Conditions Studied
Interventions
- DEVICE Remote Patient Monitoring
Study Locations (1)
Illinois
- University of Chicago Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-10-27 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
What the registry record for NCT05534932 still lists
NCT05534932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 72-participant average among 8 other Preeclampsia Postpartum trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Preeclampsia Postpartum appearing as the primary indexed condition, and to 1 intervention - of which Remote Patient Monitoring is the first listed.
NCT05534932 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05534932 about?
NCT05534932 is a clinical study titled "Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women". This is a single-center, open-label pilot study looking at how Guideline-directed management and therapy (GDMP) in post-partum women with preeclampsia can improve Global Longitudinal Strain (GLS).
What is the current status of trial NCT05534932?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-10-27. Estimated completion is 2026-11-01.
What conditions does trial NCT05534932 study?
This clinical trial studies the following conditions: Preeclampsia Postpartum.
What interventions are being tested in trial NCT05534932?
The interventions under investigation include: Remote Patient Monitoring (DEVICE).
Who is sponsoring clinical trial NCT05534932?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05534932 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia Postpartum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05534932's enrollment target sits among peer trials
20 9th of 8 the lowest of 8 other Preeclampsia Postpartum trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia Postpartum trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preeclampsia Educational Program Study (PrEPS)
ACTIVE NOT RECRUITING · NA
-
A Community Health Worker Intervention to Address Adverse Pregnancy Outcomes
COMPLETED · NA
-
Aspirin for Postpartum Patients With Preeclampsia
RECRUITING · Phase 2
-
Postpartum Low-Dose Aspirin and Preeclampsia
RECRUITING · Phase 2
-
Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia
RECRUITING · Early Phase 1
-
Aspirin and Preeclampsia
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI